Efficacy and safety of capecitabine-temozolomide (CAPTEM) regimen in patients with neuroendocrine neoplasms - experience from NETwerk, a Belgian ENETS Center of Excellence

Source
Acta gastro-enterologica belgica - ISSN 1784-3227-88:2 (2025) p. 119-127
Author(s)

Management of high-grade neuroendocrine neoplasms : impact of functional imaging.

Source
Endocrine-related cancer - ISSN 1479-6821-32:4 (2025) p. 1-11
Author(s)
    Odeta Islam, K. Sarti, Lise Verbruggen, V. Vandersmissen, K. Vanden Bulcke, L. Annys, C. Verslype, J.L. Van Laethem, H. Rezaei Kalantari, J. Janssens, A. Hendlisz, P.J. Cuyle, G. Demolin, J. Decaestecker, K. Geboes, J.C. Coche, J. Van Ongeval, W. Lybaert, M. Peeters, I. Borbath, Timon Vandamme